Bone marrow transplant and immunotherapy are two major type of myelofibrosis treatment available in market today
myelofibrosis treatment Myelofibrosis is a rare genetic disorder that affects the bone marrow. It is caused by a malfunction of the immune system. As a result, the body becomes infected with abnormal cytokines. This faulty immune system causes inflammation and results in the development of blood clots. These clots can occur in the brain, the eyes, the heart, and the veins in the legs, known as deep vein thrombosis. The progression of the disease is classified into three stages. Immunotherapy is one of the popular type of myelofibrosis treatment method. Limited awareness of the novel therapies and high costs involved in treatment are the factors restricting the growth of the global Myelofibrosis Treatment market. Symptoms may not begin immediately, as one-third of people with myelofibrosis have no symptoms when first diagnosed. The condition typically develops over time as the abnormal cells increase in number and the healthy ones decrease. Among the most common symptoms of this dis